The Planetary Society’s LightSail 2 spacecraft is continuing to sail on sunlight in Earth orbit. The high point, or apogee of the spacecraft’s orbit around the Earth was 729 kilometers on Monday, 5 August—an increase of 3.2 kilometers since sail deployment on 23 July. The spacecraft has also captured a few new images, which are available on our raw image downlink page.
Don’t worry, this was a planned end for a tiny satellite that has been a huge success.
At 14:08 UTC on 31 July, Longjiang-2, also known as DSLWP-B, passed behind the Moon for the last time. Half an hour later, with an absence of new signals to indicate a reappearance, it was clear that the Moon had lost an orbiter and gained a new crater on its far side. According to a prediction by Daniel Estévez, the 50-centimeter-tall, 47-kilogram DSLWP-B satellite impacted at 14:20 UTC.
Not to worry—this was a planned measure to prevent potential collisions or debris for future missions. A maneuver performed 24 January lowered the periapsis of the satellite’s lunar orbit by about 500 kilometers, with orbital perturbations over time seeing the satellite impacting the Moon Wednesday after 432 days in lunar orbit.
Seven years. 13 miles. 22 samples. NASA’s Curiosity Mars Rover has come a long way since touching down on the Red Planet seven years ago. See for yourself: https://www.nasa.gov/feature/jpl/new-finds-for-mars-rover-se…er-landing
NASA’s Curiosity rover has come a long way since touching down on Mars seven years ago. It has traveled a total of 13 miles (21 kilometers) and ascended 1,207 feet (368 meters) to its current location. Along the way, Curiosity discovered Mars had the conditions to support microbial life in the ancient past, among other things.
Continue reading “New Finds for Mars Rover, Seven Years After Landing” »
Genetically Modified Bacteriophages Appear To Fight Off Resistant Bacteria : Shots — Health News Treatment with genetically altered bacteriophages — viruses that attack bacteria — may have halted a patient’s near-fatal infection, hinting at new ways to fight antibiotic-resistant bacteria.
Physicists Sergio Ferrara, Dan Freedman, and Peter van Nieuwenhuizen will split a $3 million Breakthrough Prize for their theory of supergravity, which drives much of today’s physics research toward our understanding of the universe.
The Breakthrough Prize is an annual award to recognize groundbreaking science, funded by Russian-Israeli billionaire Yuri Milner. Though Breakthrough Prizes are awarded annually, “special” Breakthrough Prizes can be awarded any time and need not honor recent work. In fact, the researchers behind today’s award thought they’d missed the chance to win it.
Black holes can get pretty big, but there’s a special class that is the biggest of the big, absolute yawning monster black holes. And astronomers seem to have found an absolute specimen, clocking in at 40 billion times the mass of the Sun.
It’s at the centre of a galaxy called Holmberg 15A, a supergiant elliptical galaxy around 700 million light-years away, which in turn sits at the centre of the Abell 85 galaxy cluster.
The object is one of the biggest black holes ever found, and the biggest found by tracking the movement of the stars around it.
A soft neural implant that can be controlled by a smartphone is capable of drug delivery and optogenetics. The technology could speed up efforts to uncover the causes of neurological and psychological disorders.
The trial is just one of a few underway to test the powerful CRISPR technology around the world. One of the most promising, for example, is studying whether gene editing can treat, and effectively cure, blood disorders such as beta thalassemia and sickle cell anemia.
In beta thalassemia, the hemoglobin part of red blood cells, which is supposed to pick up oxygen from the lungs and distribute it to the cells in the rest of the body, doesn’t work properly. Patients need to be transfused with donors blood regularly, and even with these transfusions, complications can occur if the dose isn’t right and iron levels in the blood cells spike, which can lead to organ damage and even death. In sickle cell disease, a mutation in the gene that makes hemoglobin causes the red blood cells to collapse into a sickle shape, which makes it more difficult for the cells to flow smoothly through the body’s arteries and veins. Blockages caused by the misshapen blood cells can lead to severe pain and strokes.
The biotech company CRISPR Therapeutics, founded by one of the technology’s co-developers, has engineered a solution to treat both conditions that relies on genetic modifications connected to the production of fetal hemoglobin. Normally fetal hemoglobin, which provides the developing fetus with oxygen via the blood while in utero, is shut off about six months after birth, and genes for adult hemoglobin are turned on. While it’s not clear why adult hemoglobin replaces the fetal version, researchers say that they have not seen any significant differences between the two types when it comes to the ability to transport oxygen to the body’s cells. However, since the genes for adult hemoglobin don’t produce healthy red blood cells in people with beta thalassemia and sickle cell disease, one treatment strategy is to introduce genetic changes that turn on fetal hemoglobin again.
Today (Aug. 6) is going to be a big day in space!
After a Cygnus cargo spacecraft departs the International Space Station this afternoon, SpaceX and Arianespace will be launching a total of three new communications satellites into orbit. You can watch all three events live here at Space.com.
First, the Cygnus cargo ship will undock from the space station at 12:15 p.m. EDT (1615 GMT). NASA astronauts Nick Hague and Christina Koch will use the station’s Canadarm2 robotic arm to release the vessel into the vacuum of space. NASA TV will provide live coverage of the send-off beginning 15 minutes prior to its departure.
